FindTrial
Sign In

Clinical value of SAA and IL-6 in early diagnosis and severity assessment of sepsis

Clinical value of SAA and IL-6 in early diagnosis and severity assessment of sepsis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050291
Enrollment
Unknown
Registered
2021-08-25
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Gold Standard:Clinical outcome
Index test:SAA,&#32
IL-6,&#32
PCT,&#32
CRP&#32
and&#32
other&#32
tests

Sponsors

Department of Critical Care Medicine, the First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >18 years old; 2.Refer to the diagnostic criteria for each site infection and the diagnostic definition of sepsis3.0 published in 2016.

Exclusion criteria

Exclusion criteria: 1.Patients who had received antibiotics; 2.Organ transplantation; 3.Pregnancy; 4.Trauma and burns prior to admission (excluding length of stay < 24h patients).

Design outcomes

Primary

MeasureTime frame
serum amyloid A;interleukin-6;—

Countries

China

Contacts

Public ContactDeng Ximing

The First Affiliated Hospital of Bengbu Medical College

bbdxm@163.com+86 15105529908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026